I'm in the same boat as you are, eskane, but I think I'm more patient. When I bought the stock it was because I thought it was on the cutting edge of liquid biopsy, and (as far as I am concerned) that is still the case. Nothing has changed except the stock price. I suspect we eventually go higher and believe the company is likely to be purchased by some larger entity. Trust your investment decisions.
MBLY has had so many nay-sayers, it's great to see this news. It is, after all, the best of breed.
Unfortunately word does not seem to have gotten out. I think the shorts are working BIOC again.